PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
The purpose of this notice of funding opportunity (NOFO) is to support an implementation research study.
In this study, optimal strategies will be assessed for a postexposure prophylaxis (PEP) in pocket (PiP) approach for prevention of HIV and sexually transmitted infections (STIs) among disproportionately affected populations, for example, gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW).
The recipient will implement and evaluate a comprehensive strategy to integrate PEP packs as a component of existing PrEP and STI clinical services.
PEP packs will include a supply of antiretroviral medication for nonoccupational PEP (nPEP), doxycycline for STI PEP (DoxyPEP), HIV and STI self-test kits, and instruction materials.
Study clinics should be in communities with high rates of HIV diagnoses among disproportionately affected populations, for example, Black and Hispanic MSM and TGW.
In this study, optimal strategies will be assessed for a postexposure prophylaxis (PEP) in pocket (PiP) approach for prevention of HIV and sexually transmitted infections (STIs) among disproportionately affected populations, for example, gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW).
The recipient will implement and evaluate a comprehensive strategy to integrate PEP packs as a component of existing PrEP and STI clinical services.
PEP packs will include a supply of antiretroviral medication for nonoccupational PEP (nPEP), doxycycline for STI PEP (DoxyPEP), HIV and STI self-test kits, and instruction materials.
Study clinics should be in communities with high rates of HIV diagnoses among disproportionately affected populations, for example, Black and Hispanic MSM and TGW.
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,800,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,800,000
Who's Eligible
Obtain Full Opportunity Text:
https://bja.ojp.gov/funding/opportunities/o-bja-2024-172221
Additional Information of Eligibility:
N/A
Full Opportunity Web Address:
https://bja.ojp.gov/funding/opportunities/o-bja-2024-172221
Contact:
Agency Email Description:
JPatterson@cdc.gov
Agency Email:
Date Posted:
2024-12-13
Application Due Date:
Archive Date:
2025-03-21
Social Entrepreneurship
Spotlight
Social Enterprises: Key to Enhancing a Nation’s Health
Glasgow Caledonian University (GCU) has launched a series of noteworthy research projects to learn if social enterprises can help Scotland lose its “sick man of Europe” label and boost the nation’s overall health.
Learn How to Identify and Avoid Grant Scams
